More Healthcare Coverage

  • February 02, 2024

    Med Biller Who Posed As NBA Star, NFL Atty Gets 12 Years

    A Long Island medical biller was sentenced to 12 years in prison Friday after being convicted of bilking over $600 million from insurance companies through fraudulent billing submissions and impersonating NBA star Marcus Smart and the NFL's general counsel.

  • February 02, 2024

    Pa. Panel Ditches Med. Mal. Suit Over Tardy Expert Report

    A medical negligence suit over an endoscopy performed on a woman who later died won't move forward because the plaintiff filed an expert report less than one month before trial with the intent to subsequently replace that expert before trial, a Pennsylvania appellate panel has ruled, finding the doctor's trial preparation was stifled.

  • February 02, 2024

    Drugmaker Endo Wants To Extend Opioid Suit Pause

    Endo has asked a New York bankruptcy judge to pause the opioid litigation leveled against it for five more months, asserting that the pharmaceutical company made "wide-ranging progress" in its Chapter 11 case and expects to have a reorganization plan confirmed by March.

  • February 02, 2024

    Families New To Tylenol MDL Cite Expert To Avoid Dismissal

    A dozen parents and children who allege that prenatal exposure to acetaminophen caused ADHD have urged a federal judge to keep their lawsuits alive, contending that they aren't bound by an earlier ruling that barred every expert witness set to testify for plaintiffs in similar cases.

  • February 02, 2024

    Ill. COVID Wrongful Death Claims Can't Be Arbitrated

    An Illinois appeals panel has sent back to court a woman's wrongful death claims against a nursing home over her mother's death from COVID-19, saying Illinois Supreme Court precedent holds that the wrongful death claims can't be arbitrated.

  • February 02, 2024

    Pennsylvania AG's Clout In Opioid Deal Likely Has Wide Reach

    A Pennsylvania court's ruling that the attorney general had the power to overrule local district attorneys' objections to a big opioid settlement could affect the prosecutors' power dynamic beyond the painkiller litigation, overshadowing other areas where they could share jurisdiction or clash over politically sensitive issues, attorneys told Law360.

  • February 02, 2024

    Conn. Eye Patient Drops Bausch & Lomb Implant Claims

    A Connecticut woman who said she was injured by an in-eye lens implant and her husband have agreed to drop their claims against Bausch & Lomb in federal court, according to a stipulation filed by the parties following multiple appellate decisions in the couple's favor.

  • February 02, 2024

    McCarter & English To Face Revised Biotech Malpractice Suit

    A New Jersey state judge on Friday permitted a biopharmaceutical company to amend its malpractice suit against McCarter & English LLP to add new claims and avenues to collect damages, finding the changes were "sufficiently pled" and would not be prejudicial to the firm.

  • February 01, 2024

    5 Mass. Rulings You Might Have Missed In January

    Massachusetts justices in Suffolk County's Business Litigation Session weighed in on the impact of a major ruling involving Robinhood Financial, a proposed class action on overdraft fees charged by a credit union, and two pandemic-related cases. Here are five January decisions that might have flown under the radar.

  • February 01, 2024

    Healthcare Co. Owes Nearly $20M In HUD Loans, Suit Says

    A healthcare financing firm has moved to foreclose on a series of nine senior living facilities scattered throughout Illinois and Missouri, claiming the owner hasn't paid nearly $20 million in U.S. Department of Housing and Urban Development loans.

  • February 01, 2024

    Ex-Nursing Head Drops Retaliation Suit Against Colo. Hospice

    A former nursing director and the hospice care company she accused of firing her in retaliation for using Family and Medical Leave Act leave have ended their dispute, according to a stipulation of dismissal filed in Colorado federal court.

  • February 01, 2024

    Colo. Judge Trims Travel Nurses' 'Bait And Switch' Suit

    A Colorado federal judge cut several claims from a group of travel nurses' proposed class action alleging two staffing companies did a "bait and switch" and slashed their wages after hiring them, ruling they could not bring breach of contract claims because they were at-will employees.

  • February 01, 2024

    Saul Ewing Brings On Health Pro From Brach Eichler In Pa.

    Saul Ewing LLP has grown its office in the Philadelphia suburbs this week by adding an attorney formerly from Brach Eichler LLC who specializes in transaction and regulatory work in the healthcare industry.

  • January 31, 2024

    Final Immigration Fee Hikes Seen As 'Tax' On Employers

    U.S. Citizenship and Immigration Services' final fee schedule imposing fee hikes for employment-based visas and a $600 fee to fund the asylum system is drawing ire from attorneys who say it amounts to a tax on talent-strapped employers.

  • January 31, 2024

    Architect Says Steward Owes $2M For Work On Mass. Hospital

    Financially troubled Steward Health Care and its landlord owe nearly $2 million for architectural and other professional services on a project to replace one of its Massachusetts hospitals after a 2020 flood, according to a lawsuit filed in state court.

  • January 31, 2024

    Baylor Wants Nurse's Age, Disability Discrimination Suit Tossed

    Baylor University Medical Center has argued a former nurse failed to make any age-related allegations in her discrimination charge and can't establish that she's disabled, asking a Texas federal judge to grant its summary judgment motion.

  • January 31, 2024

    Doctor In NBA Fraud Case Moves To Ditch Atty, Yank Plea

    A Seattle-based physician accused of generating false invoices for a group of NBA players to submit to the league's healthcare plan has asked a Manhattan federal judge to let him drop his attorney, citing a difference of opinion over his trying to back out of his plea agreement.

  • January 31, 2024

    Mich. Hospital 'Didn't Do Its Job' For Deaf Patient, Judge Says

    A Michigan federal judge on Wednesday pressed counsel for Henry Ford Health System to explain why a deaf patient was not provided with any communication aids during a surgery, seemingly skeptical of the hospital system's defense that the chaos of the early pandemic justified the lapses.

  • January 31, 2024

    NJ Law Firm Seeks Sanctions In Malpractice Suit Led By Rival

    Mazie Slater Katz & Freeman LLC asked a New Jersey federal judge on Wednesday to impose "a substantial monetary sanction" against former-colleague-turned-rival Bruce Nagel and his firm Nagel Rice LLP, arguing that their most recent filing in its legal malpractice suit alleging Mazie Slater overcharged clients in multidistrict litigation over the blood pressure drug Benicar contains frivolous claims and baseless conclusions.

  • January 31, 2024

    Juror Misconduct Claim Sends Med Mal Case Back To Court

    An Indiana appeals panel on Wednesday reversed a trial court's denial of an evidentiary hearing following a jury verdict in favor of a doctor in a medical malpractice case, saying the lower court judge must explore an allegation of juror misconduct.

  • January 30, 2024

    1st Circ. Backs Doctor In Row Over Patent Evidence

    The First Circuit has backed a lower court jury's finding in favor of a doctor accused of fraud for not obtaining the proper consent from a patient who received an experimental therapy, rejecting an argument that the lower court didn't include evidence involving a patent.

  • January 30, 2024

    CDC Patent Apps Lead Gilead To Victory In HIV Research Feud

    The Centers for Disease Control and Prevention's repeated citation of research for HIV prevention treatments in its patent applications was key to the U.S. Court of Federal Claims concluding the government violated contracts with research partner Gilead, according to an opinion unsealed Tuesday.

  • January 30, 2024

    Philips Halts Sales Of Sleep Apnea Devices In US After Recall

    Koninklijke Philips NV revealed in a U.S. Securities and Exchange Commission filing Monday that it is halting sales of sleep apnea breathing machines in the U.S. after it began a recall in 2021 over potential health risks posed by the breakdown of sound-insulating foam.

  • January 30, 2024

    Chancery Denies Injunction Bid In Senior Housing Deal Feud

    A chancellor in the Delaware Court of Chancery on Tuesday rejected an investment firm's attempt to block a real estate company's ability to pay itself returns from a senior housing deal that went south, saying she wasn't convinced that the private equity shop would face irreparable harm otherwise.

  • January 30, 2024

    Gov't Contracts Of The Month: Satellites And AI Fighter Jets

    The federal government opened the new year with contracts seeking various military satellite capabilities, all while the U.S. Air Force pushed forward its $5.8 billion campaign for a fleet of autonomous military aircraft. These are Law360's most significant contracts in January.

Expert Analysis

  • White Collar Defense Lessons From The Bench And Beyond

    Author Photo

    Former Minnesota judge and federal prosecutor Nicole Engisch, now a partner at Dorsey & Whitney, shares insights from her background that may inform attorneys’ defense-side approach in white collar cases and corporate investigations — more relevant than ever given the U.S. Department of Justice’s recent policy changes.

  • Comparing Iowa's Data Privacy Law With Other States'

    Author Photo

    Iowa’s recently signed data privacy law is intentionally more business-friendly than other U.S. state privacy laws — as it does not apply in the business-to-business contexts and does not have a private right of action — and further entrenches the main tenets of enhanced privacy in the U.S., say attorneys at Eversheds Sutherland.

  • Ga. Needs To Resolve Cannabis Counsel Confusion

    Author Photo

    Georgia’s medical cannabis regulator finally adopted rules for low-THC oil last month, but a 2021 ethics ruling prohibits lawyers from advising participants in the state’s legal program and creates a confounding landscape that the state bar and courts must address, say Whitt Steineker and Mason Kruze at Bradley Arant.

  • 6th Circ. Ruling's Seismic Shift In FCA Kickback Causation

    Author Photo

    It is difficult to overstate the significance of the Sixth Circuit’s recent decision in the False Claims Act kickback case U.S. v. Hathaway, which shifts the government's burden of proof by adopting a more defense-friendly causation standard and curbing an expansive definition of remuneration, say attorneys at Morgan Lewis.

  • 3rd Circ. Ruling Offers Tools To Manage Exempt Employees

    Author Photo

    The Third Circuit’s recent opinion in Higgins v. Bayada Home Health, finding the Fair Labor Standards Act allows employers to deduct paid time off for missed employee productivity targets, gives companies another resource for managing exempt employee inefficiency or absenteeism, says Laura Lawless at Squire Patton.

  • Dormant Commerce Clause Issues Are Evolving In Cannabis

    Author Photo

    As federal courts across the country wrestle with how the Constitution’s dormant commerce clause applies to state-legal cannabis markets, industry stakeholders will need to watch how the issue evolves in several key contexts, including interstate compacts, say Tommy Tobin and Andrew Kline at Perkins Coie.

  • Garmon Defense Finds New Relevance As NLRB Stays Active

    Author Photo

    With a more muscular National Labor Relations Board at work, employers should recall that they have access to a powerful yet underutilized defense to state law employment and tort claims established under the U.S. Supreme Court decision in San Diego Building Trades Council v. Garmon, say Alex Meier and Cary Reid Burke at Seyfarth.

  • The Important Role Of Contra Proferentem In ERISA Cases

    Author Photo

    A Pennsylvania federal court's recent decision in Stein v. Paul Revere Life Insurance illustrates what happens when ERISA plan terms are unclear, and why the contra proferentem principle should be applied uniformly in all ERISA cases, says Mark DeBofsky at DeBofsky Law.

  • New Mich. Cannabis Policy May Lower Costs For Some Cos.

    Author Photo

    Under a recently issued bulletin from Michigan’s cannabis regulator, certain growers and processors may be able to significantly reduce costs by shifting the balance of their medical and adult-use licenses — but this strategy does entail some complications, says Robert Hendricks at Warner Norcross.

  • No Surprises Act Gives Plan Sponsors Savings Opportunities

    Author Photo

    Under the No Surprises Act, the potential savings for an ERISA group health plan and its participants are significant, and sponsors should focus on the negotiation of third-party administrator service agreements to avoid exposure to breach of fiduciary claims for payment of excessive fees, say attorneys at Hall Benefits.

  • Cos. Need Clarity On Divergent FCA Pleading Standard

    Author Photo

    With the U.S. Supreme Court’s recent denial of certiorari in three cases concerning False Claims Act pleading standards, potential FCA defendants remain subject to forum shopping, greater prosecutorial scrutiny in more lenient circuits and ambiguity that makes crafting multijurisdictional compliance policies nearly impossible, say attorneys at Troutman Pepper.

  • Time Is Ticking For Callers To Address Complex TCPA Rules

    Author Photo

    The recently published Telephone Consumer Protection Act amendments will be effective in July, giving previously exempt entities only a short time to comply with technical and onerous requirements for prerecorded, nonmarketing calls to landlines, say attorneys at Wiley.

  • What Cannabis Cos. Must Know About Strict Product Liability

    Author Photo

    To evaluate the traditional product liability risks of their products, cannabis companies should understand the common tests used by courts to determine strict liability, as well as how marijuana consumers are educated about product risks, says Ian Stewart at Wilson Elser.

Can't find the article you're looking for? Click here to search the Healthcare Authority Other archive.